EUVIMEDEUVIMED entdecken
Crossref

FXR1 Promotes Esophageal Squamous Cell Carcinoma via JAK2/STAT3/B7-H3 Pathway

Xiaoli Wang, Qianwen Miao, Xiaoyuan Liu, Fen Liu, Ying Zhang, Cailu Shen, Fang Wang, D I Shen, Xiaosong Ge

Anticancer Research · 2026

DOI: 10.21873/anticanres.18391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Xiaoli Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Affiliated Hospital of Jiangnan University, Jiangsu, P.R. China. Hauptthemen laut MEDLINE: Janus Kinase 2, STAT3 Transcription Factor, RNA-Binding Proteins, Esophageal Squamous Cell Carcinoma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus Kinase 2STAT3 Transcription FactorRNA-Binding ProteinsEsophageal Squamous Cell CarcinomaEsophageal NeoplasmsHumansAnimalsSignal TransductionMiceFemaleMaleCell Line, TumorPrognosisGene Expression Regulation, NeoplasticCell MovementMiddle AgedCell ProliferationMice, Nude

Stichwörter der Autor:innen

B7-H3FXR1JAK2/STAT3 pathwayesophageal squamous cell carcinomaprognosis

Substanzen

Janus Kinase 2STAT3 Transcription FactorJAK2 protein, humanRNA-Binding ProteinsSTAT3 protein, humanFXR1 protein, human

Autor:innen und Institutionen

  • Department of Pathology, The Affiliated Hospital of Jiangnan University, Jiangsu, P.R. China.
  • Department of Oncology, The Affiliated Hospital of Jiangnan University, Jiangsu, P.R. China.
  • Department of Pharmacy, The Affiliated Hospital of Jiangnan University, Jiangsu, P.R. China.
  • Institute of Oncology, The Affiliated Hospital of Jiangnan University, Jiangsu, P.R. China.
  • Department of Oncology, The Affiliated Hospital of Jiangnan University, Jiangsu, P.R. China; 9862016040@jiangnan.edu.cn.

Zitieren

APA

Wang, X., Miao, Q., Liu, X., Liu, F., Zhang, Y., Shen, C., Wang, F., Shen, D. I., & Ge, X. (2026). FXR1 Promotes Esophageal Squamous Cell Carcinoma via JAK2/STAT3/B7-H3 Pathway. Anticancer Research. https://doi.org/10.21873/anticanres.18391

Vancouver

Wang X, Miao Q, Liu X, Liu F, Zhang Y, Shen C, et al. FXR1 Promotes Esophageal Squamous Cell Carcinoma via JAK2/STAT3/B7-H3 Pathway. Anticancer Research. 2026. doi:10.21873/anticanres.18391

BibTeX
@article{Wang2026,
  author = {Wang, Xiaoli and Miao, Qianwen and Liu, Xiaoyuan and Liu, Fen and Zhang, Ying and Shen, Cailu and Wang, Fang and Shen, D I and Ge, Xiaosong},
  title = {FXR1 Promotes Esophageal Squamous Cell Carcinoma via JAK2/STAT3/B7-H3 Pathway},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18391}
}
Kostenlos starten →